Goldman Sachs Group Inc. has executed around £3 billion ($4 billion) of trades in Thames Water’s bonds in September, as it ...
Goldman Sachs raises gold price forecast to $2,900/oz for early 2025 ...
Earlier this month, the Federal Reserve slashed interest rates by 50 basis points at its September Federal Open Market ...
Asian developed and emerging markets net buying on Goldman Sachs' Prime book last week was the highest in 10 years, according ...
With September and the third quarter of 2024 ending, Wall Street is now focused on two things. These are the economy and the ...
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALLO), a clinical-stage biotechnology company ...
The performance of quality factors in stocks will be dictated by the direction of economic growth and interest rates, ...
Its survey found that working Americans saw improvements in their finances and retirement savings this year, but many remain ...
Goldman Sachs analyst Louise Singlehurst maintained a Buy rating on EssilorLuxottica SA (0OMK – Research Report) today and set a price ...
Goldman Sachs initiates Celldex Therapeutics 9CDLX) at neutral, citing concerns about market opportunity and lack of near-term catalysts. Read more here.
"We continue to see solid prospects for investment recovery in Greece - Another credit rating upgrade possible in the autumn" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback